E

EpiVax, Inc.

43 employees

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
deimmunization
in silico prediction
Cancer vaccines
vaccine design
Biologics Research and Development
immunogenicity risk assessment
Health Care
engineering therapeutic proteins
Deimmunization
computational immunology
immune engineering
Analytics
immunogenicity screening
Animal Health Vaccines

Date founded

1998

Funding rounds raised

Total raised

$1.5M

from 8 investors over 8 rounds

E

EpiVax, Inc. raised $600K on September 12, 2016

Investors: National Institutes of Health

E

EpiVax, Inc. raised $55K on November 1, 2012

Investors: GBS|CIDP Foundation International

E

EpiVax, Inc. raised $300K on September 5, 2012

Investors: National Institutes of Health

E

EpiVax, Inc. raised $1.5M on April 9, 2012

Investors: National Institutes of Health

E

EpiVax, Inc. raised $458K on January 25, 2011

Investors: National Institutes of Health

E

EpiVax, Inc. raised $390K on November 26, 2008

Investors: National Institutes of Health

E

EpiVax, Inc. raised $600K on July 8, 2008

Investors: National Institutes of Health

E

EpiVax, Inc. raised $368K on February 28, 2007

Investors: National Institutes of Health

FAQ